Canadian Court Upholds Lipitor Patent
After a series of unfavorable rulings for Pfizer Inc., a Canadian appeals court has upheld the pharmaceutical giant's patent for Lipitor, delivering a setback to Ranbaxy Laboratories Ltd. in its quest...To view the full article, register now.
Already a subscriber? Click here to view full article